Search and Selection of Probiotics That Improve Mucositis Symptoms in Oncologic Patients. A Systematic Review
Open Access
Abstract
Mucositis is a common and severe adverse effect of radiotherapy and/or chemotherapy treatments applied to oncologic patients. The development of effective therapies and adjuvant treatments to increase their efficacy and reduce adverse effect is a priority in cancer therapy. Probiotics are non-pathogenic live microorganisms that when ingested in adequate amounts can colonize the intestinal tract promoting the restoration of a healthy gut microbiota and contributing to all its functions including the maintenance of the integrity of the mucosa and the modulation of the immune system. In order to check the possible efficacy and safety of these microorganisms to prevent or ameliorate mucositis′ symptoms, we have systematically searched the bibliographic databases MEDLINE (via Pubmed), EMBASE, The Cochrane library, Scopus, Web of science, and Latin American and Caribbean Literature in Health of Sciences (LILACS) using the descriptors “Mucositis”, “Probiotics”, “Neoplasms”, “Humans”, and “Clinical Trials”. After applying our inclusion and exclusion criteria, 15 studies were accepted for review and critical analysis. Our analysis suggests that a combination of Bifidobacterium longum, Lactobacillus acidophilus, Bifidobacterium breve, Bifidobacterium infantis, and Saccharomyces boulardii could be a good combination of probiotics to reduce incident rates of mucositis or ameliorate its symptoms in chemo or radiotherapy treated patients.Keywords
This publication has 63 references indexed in Scilit:
- Bifidobacterium infantis35624 modulates host inflammatory processes beyond the gutGut Microbes, 2013
- Systematic review of agents for the management of gastrointestinal mucositis in cancer patientsSupportive Care in Cancer, 2012
- Lactobacillus plantarum 299v Does Not Reduce Enteric Bacteria or Bacterial Translocation in Patients Undergoing Colon ResectionDigestive Diseases and Sciences, 2012
- Probiotic supplementation affects markers of intestinal barrier, oxidation, and inflammation in trained men; a randomized, double-blinded, placebo-controlled trialJournal of the International Society of Sports Nutrition, 2012
- Evaluation of Helicobacter Pylori eradication in pediatric patients by triple therapy plus lactoferrin and probiotics compared to triple therapy aloneItalian Journal of Pediatrics, 2012
- Effects of intervention with sulindac and inulin/VSL#3 on mucosal and luminal factors in the pouch of patients with familial adenomatous polyposisInternational Journal of Colorectal Disease, 2011
- Randomised clinical trial: the effects of perioperative probiotic treatment on barrier function and post‐operative infectious complications in colorectal cancer surgery – a double‐blind studyAlimentary Pharmacology & Therapeutics, 2010
- Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignanciesSupportive Care in Cancer, 2009
- VSL#3 probiotic treatment reduces chemotherapy-induced diarrhoea and weight lossCancer Biology & Therapy, 2007
- Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancerSupportive Care in Cancer, 2006